'Its efficacy is 97.6 per cent.' Morepen India Chairman and Managing Director Sushil Suri in an interview with Uddalok Bhattacharya says the Sputnik V vaccine it is manufacturing in India......
The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms......
The medical devices, which have been in high demand during the Covid-19 pandemic, will now see a drop in prices, as the earlier margins were up to 709 per cent for some of these products. IMAGE:......
Morepen Laboratories will soon be listed on Luxembourg Stock Exchange with its global depository receipts getting 'fully subscribed' by European institutional investors and the company will seek to......
The Company Law Board on Thursday approved the fixed deposits repayment schedule plan of Morepen Laboratories Ltd.The company has fixed deposits of Rs 162 crore (Rs 1.62 billion) received through......
Morepen Laboratories has filed a suit before the Delhi high court against the Swiss-based DiaMed Scientific Laboratories, seeking an order restraining the latter from appointing any other dealer in......
Indian drugmaker Morepen Laboratories Ltd has filed an international patent for the manufacturing process of Desloratadine, the Bombay Stock Exchange said on Wednesday.The company is also working......
Morepen Laboratories expects revenues and net to rise by $20 million (Rs 1000 million) and $10-12 million (Rs 500-600 million) respectively, enhanced by a 180-day marketing exclusivity granted to......